| Literature DB >> 22911768 |
David Stucki1, Bijaya Malla, Simon Hostettler, Thembela Huna, Julia Feldmann, Dorothy Yeboah-Manu, Sonia Borrell, Lukas Fenner, Iñaki Comas, Mireia Coscollà, Sebastien Gagneux.
Abstract
There is increasing evidence that strain variation in Mycobacterium tuberculosis complex (MTBC) might influence the outcome of tuberculosis infection and disease. To assess genotype-phenotype associations, phylogenetically robust molecular markers and appropriate genotyping tools are required. Most current genotyping methods for MTBC are based on mobile or repetitive DNA elements. Because these elements are prone to convergent evolution, the corresponding genotyping techniques are suboptimal for phylogenetic studies and strain classification. By contrast, single nucleotide polymorphisms (SNP) are ideal markers for classifying MTBC into phylogenetic lineages, as they exhibit very low degrees of homoplasy. In this study, we developed two complementary SNP-based genotyping methods to classify strains into the six main human-associated lineages of MTBC, the "Beijing" sublineage, and the clade comprising Mycobacterium bovis and Mycobacterium caprae. Phylogenetically informative SNPs were obtained from 22 MTBC whole-genome sequences. The first assay, referred to as MOL-PCR, is a ligation-dependent PCR with signal detection by fluorescent microspheres and a Luminex flow cytometer, which simultaneously interrogates eight SNPs. The second assay is based on six individual TaqMan real-time PCR assays for singleplex SNP-typing. We compared MOL-PCR and TaqMan results in two panels of clinical MTBC isolates. Both methods agreed fully when assigning 36 well-characterized strains into the main phylogenetic lineages. The sensitivity in allele-calling was 98.6% and 98.8% for MOL-PCR and TaqMan, respectively. Typing of an additional panel of 78 unknown clinical isolates revealed 99.2% and 100% sensitivity in allele-calling, respectively, and 100% agreement in lineage assignment between both methods. While MOL-PCR and TaqMan are both highly sensitive and specific, MOL-PCR is ideal for classification of isolates with no previous information, whereas TaqMan is faster for confirmation. Furthermore, both methods are rapid, flexible and comparably inexpensive.Entities:
Mesh:
Year: 2012 PMID: 22911768 PMCID: PMC3401130 DOI: 10.1371/journal.pone.0041253
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Phylogenetic tree of 22 whole genome sequences of MTBC plus Mycobacterium canettii as outgroup, and canonical SNPs used for MOL-PCR and TaqMan assays.
Rv-numbers in grey arrows represent SNPs used for MOL-PCR and TaqMan in this study, respectively, and nucleotide change at the position in the annotated reference sequence of H37Rv [56]. The first number indicates the SNP used for MOL-PCR, and the italic number the SNP used for TaqMan. Assays for the “Beijing” sublineage of Lineage 2 and for M. bovis/M. caprae were developed only for MOL-PCR (modified from [51]).
Figure 2Schematic illustration of MOL-PCR.
A. Three oligonucleotides and two fluorescently labelled beads are used for interrogation of one SNP. B. MOL-PCR consists of three steps. 1. One of two competitive allele-specific left-hand probe oligonucleotides (LPO) and one universal right-hand probe oligonucleotide (RPO) are hybridized to the template DNA and ligated. 2. With PCR and a reporter-labelled forward primer, the ligated oligonucleotides (LPO+RPO) are amplified. 3. After denaturation of the PCR product, allele-specific fluorescent beads carrying an allele-specific antiTag sequence are hybridized to the amplicons. This will result in beads carrying reporter fluorescence (bead 1 in example) and beads not carrying fluorescence (bead 2). Reporter fluorescence (Alexa532) per bead is measured with a flow cytometric device (Luminex). For the 8-plex assay, a total of 24 oligonucleotides and 16 beads are used in the same reaction.
Oligonucleotides used for Luminex MOL-PCR.
| MTBC Lineage | SNP | Gene | Ess/Syn | Strand | Allele | Bead | Sequence |
| 1 | Rv3920109GT | yrbE4A | ess/syn | antisense | LPO_ancestral | 30 | GGGTTCCCTAAGGGTTGGActtaacatttaacttctataacac |
| LPO_mutant | 35 | GGGTTCCCTAAGGGTTGGAcatcttcatatcaattctcttatt | |||||
| RPO | P- | ||||||
| 2 | Rv1834177AC | rpsA | ess/syn | sense | LPO_ancestral | 12 | GGGTTCCCTAAGGGTTGGAcataatcaatttcaactttctact |
| LPO_mutant | 13 | GGGTTCCCTAAGGGTTGGAcaaatacataatcttacattcact | |||||
| RPO | P- | ||||||
| 3 | Rv301341CA | Rv0249c | ess/syn | sense | LPO_ancestral | 18 | GGGTTCCCTAAGGGTTGGAacacttatctttcaattcaattac |
| LPO_mutant | 19 | GGGTTCCCTAAGGGTTGGAatactttacaaacaaataacacac | |||||
| RPO | P- | ||||||
| 4 | Rv3326554CA | Rv2971 | ess/nonsyn. | antisense | LPO_ancestral | 20 | GGGTTCCCTAAGGGTTGGActttctcatactttcaactaattt |
| LPO_mutant | 21 | GGGTTCCCTAAGGGTTGGAtcaaactctcaattcttacttaat | |||||
| RPO | P- | ||||||
| 5 | Rv1377185CG | Rv1234 | noness/syn | sense | LPO_ancestral | 36 | GGGTTCCCTAAGGGTTGGAattaaacaactcttaactacacaa |
| LPO_mutant | 37 | GGGTTCCCTAAGGGTTGGAtacaacatctcattaacatataca | |||||
| RPO | P- | ||||||
| 6 | Rv2427828GC | Rv2164c | ess/syn | sense | LPO_ancestral | 33 | GGGTTCCCTAAGGGTTGGAactacttattctcaaactctaata |
| LPO_mutant | 34 | GGGTTCCCTAAGGGTTGGAacttatttcttcactactatatca | |||||
| RPO | P- | ||||||
|
| Rv3480645TG | Rv3113 | ess/nonsyn | sense | LPO_ancestral | 28 | GGGTTCCCTAAGGGTTGGAcacttaattcattctaaatctatc |
| LPO_mutant | 29 | GGGTTCCCTAAGGGTTGGAtactacttctataactcacttaaa | |||||
| RPO | P- | ||||||
| Beijing sublineage | Rv2112832AC | Rv1865c | noness/syn | sense | LPO_ancestral | 14 | GGGTTCCCTAAGGGTTGGAaatttcttctctttctttcacaat |
| LPO_mutant | 25 | GGGTTCCCTAAGGGTTGGActttcttaatacattacaacatac | |||||
| RPO | P- |
Nomenclature according to [2].
Position of SNP in reference to H37Rv.
SNP in an essential gene (“ess”); synonymous SNP (“syn”).
Strand orientation of oligonucleotides.
LPO, left probe oligonucleotide, annealing upstream of SNP of interest and including it; RPO, right probe oligonucleotide, annealing downstream of SNP of interest.
xTag bead with coupled antiTag-sequence.
Universal primer sequences (upper case, not underlined), allele-specific tag-sequences (lower case), and sequences hybridizing to the template genomic sequence (underlined). RPO are 5′-phosphorylated.
Primer and probe sequences for TaqMan assays.
| MTBC Lineage | LSP name | Spoligotype name | SNP | Forward primer | Reverse primer | Ancestral allele probe | Mutant allele probe | Reference |
| 1 | Indo-oceanic | EAI, MANU1 | Rv3597682CT |
|
| 6FAM-ACAAGGGCGACGTC-MGBNFQ | VIC-ACAAGGGCGACATC-MGBNFQ | This study |
| 2 | East Asian | Beijing | Rv3304966GA |
|
| 6FAM-CCCAGGAGGGTAC-MGBNFQ | VIC-CCCAGGAAGGTACT- MGBNFQ |
|
| 3 | East-African-Indian | CAS | Rv4266647AG |
|
| VIC-AAGAATGCAGCTTGTTGA-MGBNFQ | 6FAM-AAGAATGCAGCTTGTCGA- MGBNFQ |
|
| 4 | Euro-American | X, Haarlem, LAM, Uganda | Rv2154724AC |
|
| VIC-CCAGATCCTGGCATC-MGBNFQ | 6FAM-CAGATCCGGGCATC- MGBNFQ |
|
| 5 |
| AFRI 2 | Rv1377185GC |
|
| VIC-CGTGGACCTCATG-MGBNFQ | 6FAM-CGTGGACCTGATGC- MGBNFQ | This study |
| 6 |
| AFRI 1 | Rv378404GA |
|
| 6FAM-CTGCAAATCCCGCAGTA-MGBNFQ | VIC-CTGCAAATCCCACAGT- MGBNFQ | This study |
Nomenclature according to [2].
Nomenclature according to [20].
Nomenclature according to [72].
Position of SNP in reference to the H37Rv genome.
6FAM and VIC, fluorescent dyes at the 5′-end of probes; MGBNFQ, MinorGrooveBinder-NonFluorescentQuencher at the 3′-end.
Comparison of MOL-PCR and TaqMan for allele calling and lineage assignment.
| MOL-PCR | TaqMan | ||
| Training panel | Total data points | 672 (100%) | 504 (100%) |
| Data points with allele call | 662 (98.6%) | 498 (98.8%) | |
| Total number of strains | 42 (100%) | 36 (100%) | |
| Strains assigned to a lineage | 42 (100%) | 36 (100%) | |
| Congruence in lineage assignment | 100% | ||
| Test panel | Total data points | 624 (100%) | 78 (100%) |
| Data points with allele call | 619 (99.2%) | 78 (100%) | |
| Total number of strains | 78 | 78 | |
| Strains assigned to a lineage | 76 (97.4%) | 78 (100%) | |
| Congruence in lineage assignment | 100% |
excluding N/A as indicated in Table S1.
excluding M. microti, M. pinnipedi.
excluding M. bovis, M. caprae, M. microti, M. pinnipedii.
Lineage assignments of MOL-PCR, TaqMan and spoligotyping for the 46 MTBC strains as in Table S1.
| Lineage assignment | ||||||
| MTBC strain | MOL-PCR | TaqMan | Spoligotyping | Spoligotype | SITVIT lineage | SIT |
| N1004 | 1 | 1 | 1 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪□□□□▪□▪▪□▪▪▪▪▪▪ | EAI6-BGD1 | 292 |
| N1006 | 1 | 1 | 1 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪□□□▪▪▪□□□□ | EAI5 | ORPHAN |
| N0153 | 1 | 1 | - | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□□□□□□□□□□□□▪▪ | ZERO | 405 |
| N1011 | 1 | 1 | 1 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪□□□▪▪▪□□□□ | EAI5 | ORPHAN |
| N1030 | 1 | 1 | 1 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪□▪▪▪▪▪□□□□ | EAI5 | 138 |
| N1068 | 1 | 1 | 1 | ▪□□▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪□▪▪□□□▪▪▪▪ | EAI3-IND | ORPHAN |
| N1053 | 2/Beijing | 2 | 2 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ | BEIJING | 1 |
| N1002 | 2/Beijing | 2 | 2 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ | BEIJING | 1 |
| N1010 | 2/Beijing | 2 | 2 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ | BEIJING | 1 |
| N1012 | 2/Beijing | 2 | 2 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ | BEIJING | 1 |
| N0051 | 2/non-Beijing | 2 | - | □□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪ | - | 955 |
| N1069 | 2/Beijing | 2 | 2 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ | BEIJING | 1 |
| N1013 | 2/Beijing | 2 | 2 | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ | BEIJING | 1 |
| N1144 | 3 | 3 | 3 | ▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ | CAS1-DELHI | 26 |
| N1007 | 3 | 3 | 3 | ▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ | CAS | 142 |
| N1082 | 3 | 3 | 3 | ▪▪▪□□□□▪▪▪▪▪▪▪▪▪□▪▪▪▪▪□□□□□□□□□□□□▪▪▪□□□□□▪ | - | - |
| N1024 | 3 | 3 | - | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ | BEIJING | 1 |
| N1032 | 3 | 3 | 3 | ▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪ | CAS1-DELHI | 26 |
| N1021 | 3 | 3 | 3 | ▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□□□▪▪▪▪▪▪▪ | CAS | 357 |
| N1022 | 3 | 3 | 3 | ▪▪□□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□□□□□□□□▪▪□□▪▪▪▪▪ | - | 2485 |
| H37Rv | 4 | 4 | 4 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ | H37RV | 451 |
| N1008 | 4 | 4 | 4 | ▪□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪□□□□▪▪▪▪▪▪▪ | H3 | 655 |
| N1015 | 4 | 4 | 4 | ▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ | T1 | 102 |
| N1019 | 4 | 4 | 4 | ▪▪▪□▪▪▪▪□□▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪□▪▪ | - | - |
| N1052 | 4 | 4 | 4 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪ | T1 | 53 |
| N1057 | 4 | 4 | 4 | ▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□▪▪□□□□▪ | T1 | 244 |
| N1034 | 5 | 5 | 5 | ▪▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪▪▪▪▪▪□▪□□□□□□□□□▪□□□▪▪▪▪ | - | - |
| N1035 | 5 | 5 | 5 | ▪▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪▪▪▪▪▪□▪□□□□□□□□□▪□□□□▪▪▪ | - | ORPHAN |
| N1063 | 5 | 5 | 5 | ▪▪▪▪▪▪▪□□□□□□▪▪▪▪▪▪▪□□□□▪▪▪▪▪▪▪□□□□□□□□▪▪▪▪ | - | - |
| N1064 | 5 | 5 | 5 | ▪▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪▪□□□□▪▪□▪▪▪▪▪□▪▪▪□□□▪▪▪▪ | AFRI_2 | 101 |
| N1286 | 5 | 5 | 5 | ▪▪▪▪▪▪▪□□□□□▪▪▪▪▪▪▪□□□□□□□□▪▪□□□□□▪▪□□□□▪▪▪ | - | - |
| N1201 | 6 | 6 | 6 | ▪▪▪▪▪▪□□□▪▪▪▪▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□▪▪▪ | - | 3476 |
| N1292 | 6 | 6 | 6 | ▪▪▪▪▪▪□□□▪□□▪▪▪▪▪▪▪▪▪□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪ | - | - |
| N0091 | 6 | 6 | 6 | ▪▪▪▪▪▪□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪ | AFRI_1 | 181 |
| N0092 | 6 | 6 | 6 | ▪▪▪▪▪▪□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪ | AFRI_1 | 181 |
| N0115 | 6 | 6 | 6 | ▪▪▪▪▪▪□□□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪ | AFRI_1 | 181 |
|
|
| (N/A) |
| ▪▪□▪▪▪▪▪□▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□ | BOV_1 | 482 |
|
|
| (N/A) |
| ▪▪□▪▪▪▪▪□▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□ | BOV_1 | 482 |
|
|
| (N/A) |
| ▪▪□□□▪▪▪□▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪▪□□□□□ | BOV_1 | 665 |
|
|
| (N/A) |
| ▪▪□▪▪▪▪▪□▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪□□□□□ | BOV_1 | 1037 |
|
|
| (N/A) | (N/A) | □▪□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪▪▪▪□▪▪▪▪▪▪▪▪▪▪□□□□□ | BOV4_CAPRAE | 647 |
|
|
| (N/A) | (N/A) | □▪□□□□□□□□□□□□□□▪▪▪▪▪▪▪▪□□□□□□□□□□□□□□□□□□□ | BOV4_CAPRAE | 818 |
|
| - | (N/A) | (N/A) | □□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□□▪▪□□□□□ | MICROTI | 539 |
|
| - | (N/A) | (N/A) | □□□▪▪▪▪□□□□□□□□□□□□□□□▪▪□▪□□□□□□□□□□▪▪□□□□□ | PINI1 | 642 |
|
| - | (N/A) | (N/A) | □□□▪▪▪▪□□□□□□□□□□□□□□□▪▪▪▪□□▪▪▪▪▪▪▪▪▪▪□□□□□ | - | - |
|
| - | (N/A) | (N/A) | □□□▪▪▪▪□□□□□□□□□□□□□□□▪▪▪▪□□▪▪▪▪▪▪▪▪▪▪□□□□□ | - | - |
Lineage-classification using spoligotype prototypes as described in [10], [63], [64].
As described in [64].
No lineage-classification possible based on spoligotyping.
“Pseudo-Beijing” as described in [14].